Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Key metabolic effects include: Enhanced lipolysis through activation of fat breakdown pathways independent of growth hormone receptors Suppressed lipogenesis reducing conversion of non-fat substrates into stored fat Increased fat oxidation and energy expenditure in multiple species models No adverse effects on insulin sensitivity or glucose metabolism, unlike full-length growth hormone Independence from IGF-1 Signaling A critical distinction of AOD-9604 is its lack of IGF-1 pathway activation: No measurable changes in serum IGF-1 levels in human clinical trials Absence of growth-promoting effects on tissues No impact on blood glucose regulation or insulin resistance Avoidance of typical growth hormone side effects including edema and tissue overgrowth Metabolic Pathway Modulation Research indicates AOD-9604 influences energy metabolism through multiple mechanisms: Increased whole-body fat oxidation rates in animal models Enhanced metabolic rate without stimulant-like effects Potential modulation of uncoupling proteins in adipose tissue Effects on lipid metabolism that persist beyond plasma clearance Critical Mechanistic Gap: Despite extensive research, the primary receptor target for AOD-9604 remains unidentified
"Functioning Pituitary Adenomas - Current Treatment Options and Emerging Medical Therapies"
The best peptides for fat loss target specific hormonal pathways: some boost growth hormone secretion, others suppress appetite, and some directly break down stored adipose tissue
A recombinant form of HGH called somatropin (INN) is used as a prescription drug to treat children's growth disorders and adult growth hormone deficiency
We are here to help you get answers and find the right path toward improved well-being
US$ 25.00
US$ 21.84
US$ 24.23
US$ 24.95
US$ 29.59
US$ 28.07
US$ 24.36
US$ 28.82
US$ 21.27
